Hepatology Journal Citation Rate 2026
0270-9139
eISSN 1527-3350
Lippincott Williams & Wilkins
US
Q1 Quartile Top Tier
About Hepatology
Hepatology (H) is a peer-reviewed academic journal, published by Lippincott Williams & Wilkins in US, catalogued under ISSN 0270-9139 (e-ISSN 1527-3350). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 5.98 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.
Hepatology Citation Rate 2026 — In Context
Hepatology has a 2025 2-Year Citation Rate (OpenAlex) of 5.98, placing it in the Q1 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Hepatology operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Hepatology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Hepatology against similar journals in the field, use our journal comparison tool.
| ISSN (Print) | 0270-9139 |
|---|---|
| ISSN (Online) | 1527-3350 |
| Publisher | Lippincott Williams & Wilkins |
| Country | United States |
| APC / Cost | Inquire with Publisher |
In-depth profile & metrics
Hepatology is published by Lippincott Williams & Wilkins and based in United States.
Its most recent citation rate stands at 5.975.
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Hepatology
Live Indexing Status
Updated July 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 5.975 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Research Highlights
Recently published high-impact papers in this journal:
-
Efficacy of Sequential Transarterial Chemoembolization after Stereotactic Body Radiation Therapy versus Radiation Therapy Alone for Recurrent Hepatocellular Carcinoma: A Propensity Score-matched Analysis
Jian-Hui Wu, Junqiang Ding, Jing Sun • 2026
-
Dyslipidemia in liver cirrhosis: Pathophysiology and emerging therapeutic approaches
Jenyfer M Fuentes-Mendoza, Marcio J Concepción-Zavaleta, Jeny J Mendoza-Godoy • 2026
-
From steatosis to inflammation: Innate lymphocytes as hidden orchestrators in metabolic dysfunction-associated steatotic liver disease
César Alejandro San Juan-García, Rita I Escamilla, Lucia Cruz-Romero • 2026
-
Acute liver failure linked to OxyShred pre-workout supplement: A case report and review of literature
Sarah Householder, Noah Brazer, Ysabel C Ilagan-Ying • 2026
-
Survival gap in gallbladder cancer: Bridging tumor biology and healthcare system logistics
Bruno Mirandola Bulisani • 2026
Explore More Journals
Metadata
Last updated: Jul 12, 2026
Updated by: system
Get weekly updates
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.